Rekah Pharmaceutical Industry Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Sales 2022 | 292M 78.93M 6.57B | Sales 2023 | 322M 86.83M 7.23B | Capitalization | 169M 45.54M 3.79B |
---|---|---|---|---|---|
Net income 2022 | -2M -540K -44.95M | Net income 2023 | -6M -1.62M -135M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 145M 39.25M 3.27B | Net Debt 2023 | 166M 44.93M 3.74B | EV / Sales 2023 | 1.04 x |
P/E ratio 2022 |
-85.5
x | P/E ratio 2023 |
-24.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 24/93/24 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/18/01 |
Director/Board Member | 78 | 24/93/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/15/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/15/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/15/15 |
1st Jan change | Capi. | |
---|---|---|
+21.93% | 73.38B | |
-1.71% | 24.13B | |
+10.34% | 8.59B | |
-19.80% | 8.06B | |
+14.16% | 5.26B | |
-0.03% | 4.21B | |
+12.70% | 4.17B | |
-2.54% | 3.89B | |
+24.00% | 3.71B |